Alvotech
Founded in 2013, Alvotech is a specialty biopharmaceutical company dedicated to developing and manufacturing high-quality biosimilar medicines. Its mission is to enhance patients' health and quality of life worldwide by increasing access to effective therapies for various ailments.
Top Stages
1 past transactions
Baliopharm
Acquisition in 2016
Baliopharm is a biotechnology company focused on the development of novel therapeutics for immune-mediated inflammatory diseases and cancer. It develops antibody-derived therapeutics, including monoclonal antibodies, monovalent formats, and bispecifics, aimed at improving target selectivity and safety. The company is headquartered in Basel, Switzerland, with a research presence in Jülich, Germany, and concentrates on treating autoimmune diseases such as rheumatoid arthritis, Crohn's disease, psoriasis, and multiple sclerosis, as well as various cancers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.